학술논문
Chemotherapy response score (CRS) as a surrogate marker for homologous recombination deficiency (HRD) based on loss of heterozygosity (LOH) in high grade serous ovarian cancer (HGSOC)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
10956859